logo

PLSE

Pulse Biosciences
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 1
Sell signal 0
stock price surged significantly

Key Stats

--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

About PLSE

Pulse Biosciences, Inc.

A novel bioelectric medicine company that develops medical devices based on a nano-pulse electro signaing platform for the treatment of tumors

Healthcare Equipment and Supplies
05/19/2014
05/18/2016
NASDAQ Stock Exchange
75
12-31
Common stock
3957 Point Eden Way, Hayward, CA 94545
--
Pulse Biosciences, Inc., incorporated in Nevada on May 19, 2014 under the name Electroblate, Inc., is a medical device company using a new and proprietary platform technology, nano-pulsed electrical signaling, or NPES in the developmental stage of biomedical applications. Electroblate, Inc., was renamed Pulse Biosciences Corporation, effective December 8, 2015.

Company Financials

EPS

PLSE has released its 2024 Q4 earnings. EPS was reported at -0.17, versus the expected -0.24, beating expectations. The chart below visualizes how PLSE has performed over recent quarters, highlighting trends in earnings surprises.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime